Zynex Inc (ZYXI) revealed its plan to initiate a share buyback program, authorizing the repurchase of up to $10.0 million of its common stock
Zynex Inc (ZYXI), a medical technology company, has recently made an announcement about a newstock buyback program. Zynex revealed its plan to initiate a share buyback program, authorizing the repurchase of up to $10.0 million of its common stock.
The share buyback program is scheduled to commence on June 14, 2023, and is anticipated to conclude on June 13, 2024, or when the buyback limit of $10.0 million is reached. Zynex aims to utilize its available cash balances to fund the purchases, which are not expected to significantly impact its capital levels.
Join LevelFields now to be the first to know about events that affect stock prices and uncover unique investment opportunities. Choose from events, view price reactions, and set event alerts with our AI-powered platform. Don't miss out on daily opportunities from 6,300 companies monitored 24/7. Act on facts, not opinions, and let LevelFields help you become a better trader.